Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03323450 : Cognitive Remediation Therapy for Brain Tumor Patients: Improving Working Memory
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Confirmed primary brain tumor diagnosis via MRI and their neuro-oncologist

- A minimum of 2 months post-surgical resection or biopsy(if applicable)

- and/or a minimum 1 month post radiation treatment (if applicable)

- Karnofsky performance status more than 60

- Estimated intelligence at least 80 (standard score)

- Demonstrated attention difficulties (T-score of at least 65 on attention questionnaire
or 1 or more standard deviations below mean on direct attention measures)

- No history of cognitive disorder

- No history of mood disorder

- Predicted life expectancy of at least 12 months

- Computer capability at home or provided a departmental iPad Mini to borrow for study
purposes

- Primarily English speaking

- Aged 18+ (for which there is available age-adjusted neuropsychological testing
standardization / normative data)

Exclusion Criteria:

- If they are not patients of Massey Cancer Center or do not meet the inclusion criteria
listed above
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03323450      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740